array:24 [
  "pii" => "S0213911102719730"
  "issn" => "02139111"
  "doi" => "10.1016/S0213-9111(02)71973-0"
  "estado" => "S300"
  "fechaPublicacion" => "2002-11-01"
  "aid" => "71973"
  "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
  "copyrightAnyo" => "2002"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Gac Sanit. 2002;16:511-20"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 5584
    "formatos" => array:3 [
      "EPUB" => 162
      "HTML" => 4794
      "PDF" => 628
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0213911102719742"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(02)71974-2"
    "estado" => "S300"
    "fechaPublicacion" => "2002-11-01"
    "aid" => "71974"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Gac Sanit. 2002;16:521-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2882
      "formatos" => array:3 [
        "EPUB" => 118
        "HTML" => 2307
        "PDF" => 457
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "521"
          "paginaFinal" => "525"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "(Employees attitudes to workplace health promotion programs for cancer prevention)"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M. Sala, G. Janer, C. Font, I. Garau, M.D. Solé, T. Corbella, T. Partanen, M. Kogevinas"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "M."
              "apellidos" => "Sala"
            ]
            1 => array:2 [
              "nombre" => "G."
              "apellidos" => "Janer"
            ]
            2 => array:2 [
              "nombre" => "C."
              "apellidos" => "Font"
            ]
            3 => array:2 [
              "nombre" => "I."
              "apellidos" => "Garau"
            ]
            4 => array:2 [
              "nombre" => "M.D."
              "apellidos" => "Solé"
            ]
            5 => array:2 [
              "nombre" => "T."
              "apellidos" => "Corbella"
            ]
            6 => array:2 [
              "nombre" => "T."
              "apellidos" => "Partanen"
            ]
            7 => array:2 [
              "nombre" => "M."
              "apellidos" => "Kogevinas"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719742?idApp=WGSE"
    "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719742/v1_201310251643/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0213911102719729"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(02)71972-9"
    "estado" => "S300"
    "fechaPublicacion" => "2002-11-01"
    "aid" => "71972"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Gac Sanit. 2002;16:505-10"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2638
      "formatos" => array:3 [
        "EPUB" => 134
        "HTML" => 2091
        "PDF" => 413
      ]
    ]
    "es" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Aceptación de los fármacos genéricos en equipos de atención primaria: efecto de una intervención educativa y de los precios de referencia"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "505"
          "paginaFinal" => "510"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "en" => array:1 [
          "titulo" => "(Acceptance of generic prescribing in general practice: effect of patient education and reference prices)"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J.A. Vallès, M. Barreiro, G. Cereza, J.J. Ferro, M.J. Martínez, E. Cucurull, E. Barceló"
          "autores" => array:7 [
            0 => array:2 [
              "nombre" => "J.A."
              "apellidos" => "Vallès"
            ]
            1 => array:2 [
              "nombre" => "M."
              "apellidos" => "Barreiro"
            ]
            2 => array:2 [
              "nombre" => "G."
              "apellidos" => "Cereza"
            ]
            3 => array:2 [
              "nombre" => "J.J."
              "apellidos" => "Ferro"
            ]
            4 => array:2 [
              "nombre" => "M.J."
              "apellidos" => "Martínez"
            ]
            5 => array:2 [
              "nombre" => "E."
              "apellidos" => "Cucurull"
            ]
            6 => array:2 [
              "nombre" => "E."
              "apellidos" => "Barceló"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719729?idApp=WGSE"
    "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719729/v1_201310251643/es/main.assets"
  ]
  "es" => array:14 [
    "idiomaDefecto" => true
    "titulo" => "El coste de la diabetes tipo 2 en España. El estudio CODE-2"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "511"
        "paginaFinal" => "520"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "M. Mata, F. Antoñanzas, M. Tafalla, P. Sanz"
        "autores" => array:4 [
          0 => array:3 [
            "nombre" => "M."
            "apellidos" => "Mata"
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "F&#46;"
            "apellidos" => "Anto&#241;anzas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "M&#46;"
            "apellidos" => "Tafalla"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "P&#46;"
            "apellidos" => "Sanz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "CAP La Mina&#46; Sant Adri&#224; de Bes&#242;s&#46; Barcelona"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Departamento de Econom&#237;a y Empresa&#46; Universidad de la Rioja"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Pharma Research&#46; Pharma-Consult Services&#44; S&#46;A&#46; Madrid"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#42;"
            "correspondencia" => "Correspondencia&#58; Juan Ragel&#46; Pharma Consult Services&#44; S&#46;A&#46; Avda&#46; Burgos&#44; 12&#44; 9&#46;a planta&#46; 28036 Madrid&#46;Correo electr&#243;nico&#58; Jragel&#64;pharma-consult&#46;es"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "en" => array:1 [
        "titulo" => "&#40;The cost of type 2 diabetes in Spain&#58; the CODE-2 study&#41;"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2002-02-05"
    "fechaAceptado" => "2002-09-30"
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec268818"
          "palabras" => array:3 [
            0 => "Diabetes tipo 2"
            1 => "Coste"
            2 => "Farmacoeconom&#237;a"
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key words"
          "identificador" => "xpalclavsec268819"
          "palabras" => array:4 [
            0 => "Type 2 diabetes"
            1 => "Cost"
            2 => "Pharmacoeconomic study"
            3 => "Spain"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<span class="elsevierStyleSectionTitle">Objetivo</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Estimar el coste de la atenci&#243;n sanitaria al paciente diab&#233;tico tipo 2&#44; diferenciando el gasto derivado del control de la enfermedad&#44; de la atenci&#243;n de sus complicaciones y de otros costes directos asociados&#46;</p> <span class="elsevierStyleSectionTitle">M&#233;todos</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Recogida retrospectiva del consumo de recursos a partir de la historia cl&#237;nica y la entrevista personal en 29 centros de atenci&#243;n primaria de todo el territorio nacional de una muestra de pacientes seleccionados de forma aleatoria a partir del registro de diab&#233;ticos de cada centro&#46;</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Se evalu&#243; a 1&#46;004 pacientes &#40;561 mujeres&#41; con una media de edad de 67&#44;42 a&#241;os y una media de evoluci&#243;n de la enfermedad de 10&#44;07 a&#241;os&#46; El 50&#44;9&#37; no presentaba complicaciones&#44; el 17&#44;7&#37; s&#243;lo macrovasculares&#44; el 19&#44;5&#37; s&#243;lo microvasculares y el 11&#44;9&#37; ambas&#46; El coste anual sanitario por paciente fue de 1&#46;305&#44;15 euros&#46; De este coste el 28&#44;6&#37; &#40;373&#44;27 euros&#41; estaba relacionado directamente con el control de la diabetes&#44; el 30&#44;51&#37; &#40;398&#44;20 euros&#41; con sus complicaciones y el 40&#44;89&#37; &#40;533&#44;68 euros&#41; no estaba relacionado&#46; El coste medio de un paciente sin complicaciones fue de 883 euros frente a 1&#46;403 de un paciente con complicaciones microvasculares&#44; 2&#46;022 cuando exist&#237;an complicaciones macrovasculares y 2&#46;133 cuando coexist&#237;an ambos tipos de complicaciones&#46;</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">El elevado coste del tratamiento de la diabetes tipo 2 y sus complicaciones&#44; sugiere la posibilidad de que la mejora del control de la enfermedad pueda no s&#243;lo mejorar la supervivencia y la calidad de vida&#44; sino reducir los costes asociados con las complicaciones cr&#243;nicas&#46;</p>"
      ]
      "en" => array:2 [
        "titulo" => "Summary"
        "resumen" => "<span class="elsevierStyleSectionTitle">Objective</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To estimate the cost of providing health care to patients with type 2 diabetes&#44; by differentiating costs of the disease&#44; costs of complications&#44; and other unrelated health costs&#46;</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Data on resource use were retrospectively collected from medical records and personal interviews in 29 primary health care centers in Spain&#46; Patients were randomly selected from each center&#39;s diabetes registry&#46;</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">We evaluated 1004 patients &#40;561 women&#41; with a mean age of 67&#46;42 years and a mean disease duration of 10&#46;07 years&#46; A total of 50&#46;9&#37; had no complications&#44; 17&#46;7&#37; had macrovascular complications only&#44; 19&#46;5&#37; had microvascular complications only and 11&#46;9&#37; presented both types of complication&#46; The annual health cost per patient was 1305&#46;15 euros&#46; Of this cost&#44; 28&#46;6&#37; &#40;373&#46;27 euros&#41; was directly related to diabetes control&#44; 30&#46;51&#37; &#40;398&#46;20 euros&#41; was related to complications of the disease&#44; and 40&#46;89&#37; &#40;533&#46;68 euros&#41; was unrelated&#46; The mean cost of patients with no complications was 883 euros compared with 1403 euros for those with microvascular complications&#44; 2022 euros for those with macrovascular complications and 2133 euros for patients with both types of complication&#46;</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Because of the high cost of treating type 2 diabetes and its complications&#44; preventive measures should be implemented and control of the disease should be improved to reduce the costs associated with chronic complications&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Biblograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:30 [
            0 => array:3 [
              "identificador" => "bib1"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:1 [
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "Consenso para la Atenci&#243;n a las Personas con Diabetes en Espa&#241;a"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "LibroEditado" => array:1 [
                        "serieFecha" => "1994"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib2"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patiens with 2 diabetes &#40;UKPDS 33&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "UK Prospective Diabetes Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "1998"
                        "volumen" => "352"
                        "paginaInicial" => "837"
                        "paginaFinal" => "853"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9742976"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib3"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patiens &#40;UKPDS 34&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "UK Prospective Diabetes Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "1998"
                        "volumen" => "352"
                        "paginaInicial" => "854"
                        "paginaFinal" => "865"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9742977"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib4"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes&#58; UKPDS 38"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "UK Prospective Diabetes Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "1998"
                        "volumen" => "317"
                        "paginaInicial" => "703"
                        "paginaFinal" => "713"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9732337"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib5"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An&#225;lisis coste-efectividad de la automonitorizaci&#243;n de la glucosa sangu&#237;nea en diab&#233;ticos tipo 2"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;L&#46; Clua Espuny"
                            1 => "J&#46; Puig Junoy"
                            2 => "M&#46;L&#46; Queralt Tom&#225;s"
                            3 => "A&#46; Palau Galindo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Gac Sanit"
                        "fecha" => "2000"
                        "volumen" => "14"
                        "paginaInicial" => "442"
                        "paginaFinal" => "448"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11270170"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib6"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Impacto econ&#243;mico de la diabetes mellitus en los costes de hospitalizaci&#243;n"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Pascual"
                            1 => "C&#46; Gonzalez"
                            2 => "S&#46; De Juan"
                            3 => "C&#46; S&#225;nchez"
                            4 => "B&#46; S&#225;nchez"
                            5 => "M&#46; P&#233;rez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1996"
                        "volumen" => "107"
                        "paginaInicial" => "207"
                        "paginaFinal" => "210"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib7"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "El coste de la diabetes mellitus conocida en Espa&#241;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "W&#46;M&#46; Hart"
                            1 => "C&#46; Espinosa"
                            2 => "J&#46; Rovira"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1997"
                        "volumen" => "109"
                        "paginaInicial" => "289"
                        "paginaFinal" => "293"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib8"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes &#8211; The cost of illness and the cost of control"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "B&#46; J&#246;nnson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Acta Med Scand"
                        "fecha" => "1983"
                        "volumen" => "671"
                        "numero" => "Suppl"
                        "paginaInicial" => "19"
                        "paginaFinal" => "27"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib9"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "R&#46;M&#46; Kaplan"
                            1 => "W&#46;K&#46; Davis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "1986"
                        "volumen" => "9"
                        "paginaInicial" => "81"
                        "paginaFinal" => "86"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3081308"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib10"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes mellitus and the St Vivent Declaration&#46; The economic implications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "B&#46; Leese"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Pharmaco-Economics"
                        "fecha" => "1995"
                        "volumen" => "7"
                        "paginaInicial" => "292"
                        "paginaFinal" => "307"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib11"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "La versi&#243;n espa&#241;ola del EuroQol&#58; descripci&#243;n y sus aplicaciones&#46; Escala Europea de Calidad"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "X&#46; Badia"
                            1 => "M&#46; Roset"
                            2 => "S&#46; Montserrat"
                            3 => "M&#46; Herdman"
                            4 => "A&#46; Segura"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1999"
                        "volumen" => "112"
                        "numero" => "Supl 1"
                        "paginaInicial" => "79"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib12"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Kosten des Typ-2-Diabetes in Deutschland&#46; Ergebnisse der CODE-2 Studie"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "A&#46; Liebl"
                            1 => "A&#46; Neiss"
                            2 => "A&#46; Spannheimer"
                            3 => "U&#46; Reitberger"
                            4 => "T&#46; Wagner"
                            5 => "A&#46; Go&#235;rtz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1055/s-2001-14102"
                      "Revista" => array:6 [
                        "tituloSerie" => "Dtsch Med Wschr"
                        "fecha" => "2001"
                        "volumen" => "126"
                        "paginaInicial" => "585"
                        "paginaFinal" => "589"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11402924"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib13"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consommation de soins et de Biens m&#233;dicaux des diab&#233;tiques de type 2 en France en 1998"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Detournay"
                            1 => "F&#46; Fagnani"
                            2 => "C&#46; Pribil"
                            3 => "E&#46; Eschwege"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10719-015-9578-6"
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes &#38; Metabolism &#40;Paris&#41;"
                        "fecha" => "2000"
                        "volumen" => "26"
                        "paginaInicial" => "225"
                        "paginaFinal" => "231"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25796617"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib14"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes y farmacoeconom&#237;a&#46; Eficiencia de los m&#233;todos inyectables de insulina disponibles en Espa&#241;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46; Costa"
                            1 => "A&#46; Estopa"
                            2 => "J&#46; Borras"
                            3 => "A&#46; Sabate"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aten Primaria"
                        "fecha" => "1995"
                        "volumen" => "16"
                        "paginaInicial" => "391"
                        "paginaFinal" => "396"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7495947"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib15"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumo de medicamentos en la diabetes mellitus 2&#46; Utilizaci&#243;n y p&#233;rdida de insulina&#58; epidemiolog&#237;a e implicaciones socioecon&#243;micas&#46; Grupo de estudio de la diabetes de Tarragona"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "B&#46; Costa"
                            1 => "J&#46;F&#46; Monclus"
                            2 => "M&#46; Huguet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1993"
                        "volumen" => "100"
                        "paginaInicial" => "241"
                        "paginaFinal" => "244"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib16"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Consumo de medicamentos en diabetes mellitus &#40;IV&#41;&#46; Utilizaci&#243;n de material reactivo y sistemas de control de la glucosa en sangre desde el punto de vista de la atenci&#243;n primaria&#46; Grupo de estudio de la diabetes en Tarragona"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "B&#46; Costa"
                            1 => "M&#46; Huguet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "1994"
                        "volumen" => "102"
                        "paginaInicial" => "321"
                        "paginaFinal" => "324"
                        "itemHostRev" => array:3 [
                          "pii" => "S0091674903008704"
                          "estado" => "S300"
                          "issn" => "00916749"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib17"
              "etiqueta" => "17&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Automonitorizaci&#243;n de la glucosa en sangre&#58; evaluaci&#243;n de su prescripci&#243;n y resultados en diabetes tipo 2&#46; Grupo de investigaci&#243;n en atenci&#243;n primaria de Tortosa"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;L&#46; Clua Espuny"
                            1 => "J&#46; Puig Junoy"
                            2 => "E&#46; Ciurana Roca"
                            3 => "G&#46; Garc&#237;a Bernal"
                            4 => "J&#46;F&#46; Monclus Benet"
                            5 => "A&#46; Gonz&#225;lez Henares"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Aten Primaria"
                        "fecha" => "1999"
                        "volumen" => "24"
                        "paginaInicial" => "316"
                        "paginaFinal" => "325"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10596221"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib18"
              "etiqueta" => "18&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Economic consequences of diabetes mellitus in the US in 1997"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "American Diabetes Association"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "1998"
                        "volumen" => "21"
                        "paginaInicial" => "296"
                        "paginaFinal" => "309"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9539999"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib19"
              "etiqueta" => "19&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The cost of diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "K&#46; Gerard"
                            1 => "C&#46; Donaldson"
                            2 => "A&#46;K&#46; Maynard"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetic Med"
                        "fecha" => "1989"
                        "volumen" => "6"
                        "paginaInicial" => "164"
                        "paginaFinal" => "170"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2522861"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib20"
              "etiqueta" => "20&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes&#58; economic analysis alongside randomised controlled trial &#40;UKPDS 41&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Gray"
                            1 => "M&#46; Raikou"
                            2 => "A&#46; McGuire"
                            3 => "P&#46; Fenn"
                            4 => "R&#46; Stevens"
                            5 => "C&#46; Cull"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2000"
                        "volumen" => "320"
                        "paginaInicial" => "1373"
                        "paginaFinal" => "1378"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10818026"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            20 => array:3 [
              "identificador" => "bib21"
              "etiqueta" => "21&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Direct medical costs for patients with type 2 diabetes in Sweden"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46; Henriksson"
                            1 => "C&#46;D&#46; Agardh"
                            2 => "C&#46; Berne"
                            3 => "J&#46; Bolinder"
                            4 => "F&#46; L&#246;nnqvist"
                            5 => "P&#46; Stenstr&#246;m"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Intern Med"
                        "fecha" => "2000"
                        "volumen" => "248"
                        "paginaInicial" => "387"
                        "paginaFinal" => "396"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11123503"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            21 => array:3 [
              "identificador" => "bib22"
              "etiqueta" => "22&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Costi e profili di trattamento farmacologico nei pazienti con diabete di tipo 2&#58; i risultati dello studio CODE-2"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Lucioni"
                            1 => "S&#46; Mazzi"
                            2 => "G&#46; Serra"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Pharmacoeconomics-Italian Research Articles"
                        "fecha" => "2001"
                        "volumen" => "3"
                        "paginaInicial" => "1"
                        "paginaFinal" => "14"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            22 => array:3 [
              "identificador" => "bib23"
              "etiqueta" => "23&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes &#40;UKPDS 40&#41;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "UK Prospective Diabetes Study Group"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "1998"
                        "volumen" => "317"
                        "paginaInicial" => "720"
                        "paginaFinal" => "726"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9732339"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0091674902014161"
                          "estado" => "S300"
                          "issn" => "00916749"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            23 => array:3 [
              "identificador" => "bib24"
              "etiqueta" => "24&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Diabetes in Canada&#58; direct medical costs of major macrovascular complications"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "J&#46;A&#46; O&#39;Brien"
                            1 => "I&#46; Caro"
                            2 => "D&#46; Getsios"
                            3 => "J&#46;J&#46; Caro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1046/j.1524-4733.2001.43017.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Value in Health"
                        "fecha" => "2001"
                        "volumen" => "4"
                        "paginaInicial" => "258"
                        "paginaFinal" => "265"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11705187"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            24 => array:3 [
              "identificador" => "bib25"
              "etiqueta" => "25&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "An economic analysis of interventions for Diabetes"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "D&#46; Klonoff"
                            1 => "D&#46; Schwartz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2000"
                        "volumen" => "23"
                        "paginaInicial" => "390"
                        "paginaFinal" => "404"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10868871"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            25 => array:3 [
              "identificador" => "bib26"
              "etiqueta" => "26&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "The Diabetes Control and Complications Trial Research Group &#40;DCCT&#41;"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "1996"
                        "volumen" => "276"
                        "paginaInicial" => "1409"
                        "paginaFinal" => "1415"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8892716"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            26 => array:3 [
              "identificador" => "bib27"
              "etiqueta" => "27&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Model of complications of NIDDM II&#46; Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "R&#46;C&#46; Eastman"
                            1 => "J&#46;C&#46; Javitt"
                            2 => "W&#46;H&#46; Herman"
                            3 => "E&#46;J&#46; Dasbach"
                            4 => "C&#46; Copley-Merriman"
                            5 => "W&#46; Maier"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "1997"
                        "volumen" => "20"
                        "paginaInicial" => "685"
                        "paginaFinal" => "686"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9135926"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            27 => array:3 [
              "identificador" => "bib28"
              "etiqueta" => "28&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The validity of the EQ-5D in children with asthma&#46; 16th Plenary Meeting of the EuroQol Group"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46; Roset"
                            1 => "X&#46; Badia"
                            2 => "A&#46; Benavides"
                            3 => "M&#46; Herdman"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Sitges&#44; Spain"
                        "fecha" => "1999&#44; noviembre"
                        "paginaInicial" => "6"
                        "paginaFinal" => "9"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            28 => array:3 [
              "identificador" => "bib29"
              "etiqueta" => "29&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Badia X&#44; Roset M&#44; L&#243;pez-David C&#44; Herdman M&#46; Is the EQ-5D useful in estimating use of health resources in a cohort of HIV patients&#63; 17th Plenary Meeting of the EuroQol Group&#46;"
                ]
              ]
            ]
            29 => array:3 [
              "identificador" => "bib30"
              "etiqueta" => "30&#46;"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Badia X&#44; Roset M&#44; Herdman M&#44; Kind P&#46; A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states&#46; Medical Decision Making"
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02139111/0000001600000006/v1_201310251643/S0213911102719730/v1_201310251643/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "18705"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Originales"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02139111/0000001600000006/v1_201310251643/S0213911102719730/v1_201310251643/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911102719730?idApp=WGSE"
]
Compartir
Publique en esta revista
Información de la revista
Vol. 16. Núm. 6.
Páginas 511-520 (noviembre - diciembre 2002)
Respuestas rápidas
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 16. Núm. 6.
Páginas 511-520 (noviembre - diciembre 2002)
Open Access
El coste de la diabetes tipo 2 en España. El estudio CODE-2
(The cost of type 2 diabetes in Spain: the CODE-2 study)
Visitas
9187
M. Mataa,*, F. Antoñanzasb, M. Tafallac, P. Sanzc
a CAP La Mina. Sant Adrià de Besòs. Barcelona
b Departamento de Economía y Empresa. Universidad de la Rioja
c Pharma Research. Pharma-Consult Services, S.A. Madrid
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Objetivo

Estimar el coste de la atención sanitaria al paciente diabético tipo 2, diferenciando el gasto derivado del control de la enfermedad, de la atención de sus complicaciones y de otros costes directos asociados.

Métodos

Recogida retrospectiva del consumo de recursos a partir de la historia clínica y la entrevista personal en 29 centros de atención primaria de todo el territorio nacional de una muestra de pacientes seleccionados de forma aleatoria a partir del registro de diabéticos de cada centro.

Resultados

Se evaluó a 1.004 pacientes (561 mujeres) con una media de edad de 67,42 años y una media de evolución de la enfermedad de 10,07 años. El 50,9% no presentaba complicaciones, el 17,7% sólo macrovasculares, el 19,5% sólo microvasculares y el 11,9% ambas. El coste anual sanitario por paciente fue de 1.305,15 euros. De este coste el 28,6% (373,27 euros) estaba relacionado directamente con el control de la diabetes, el 30,51% (398,20 euros) con sus complicaciones y el 40,89% (533,68 euros) no estaba relacionado. El coste medio de un paciente sin complicaciones fue de 883 euros frente a 1.403 de un paciente con complicaciones microvasculares, 2.022 cuando existían complicaciones macrovasculares y 2.133 cuando coexistían ambos tipos de complicaciones.

Conclusiones

El elevado coste del tratamiento de la diabetes tipo 2 y sus complicaciones, sugiere la posibilidad de que la mejora del control de la enfermedad pueda no sólo mejorar la supervivencia y la calidad de vida, sino reducir los costes asociados con las complicaciones crónicas.

Palabras clave:
Diabetes tipo 2
Coste
Farmacoeconomía
Summary
Objective

To estimate the cost of providing health care to patients with type 2 diabetes, by differentiating costs of the disease, costs of complications, and other unrelated health costs.

Methods

Data on resource use were retrospectively collected from medical records and personal interviews in 29 primary health care centers in Spain. Patients were randomly selected from each center's diabetes registry.

Results

We evaluated 1004 patients (561 women) with a mean age of 67.42 years and a mean disease duration of 10.07 years. A total of 50.9% had no complications, 17.7% had macrovascular complications only, 19.5% had microvascular complications only and 11.9% presented both types of complication. The annual health cost per patient was 1305.15 euros. Of this cost, 28.6% (373.27 euros) was directly related to diabetes control, 30.51% (398.20 euros) was related to complications of the disease, and 40.89% (533.68 euros) was unrelated. The mean cost of patients with no complications was 883 euros compared with 1403 euros for those with microvascular complications, 2022 euros for those with macrovascular complications and 2133 euros for patients with both types of complication.

Conclusions

Because of the high cost of treating type 2 diabetes and its complications, preventive measures should be implemented and control of the disease should be improved to reduce the costs associated with chronic complications.

Key words:
Type 2 diabetes
Cost
Pharmacoeconomic study
Spain
El Texto completo está disponible en PDF
Biblografía
[1.]
Consenso para la Atención a las Personas con Diabetes en España.
[2.]
UK Prospective Diabetes Study Group.
Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patiens with 2 diabetes (UKPDS 33).
Lancet, 352 (1998), pp. 837-853
[3.]
UK Prospective Diabetes Study Group.
Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patiens (UKPDS 34).
Lancet, 352 (1998), pp. 854-865
[4.]
UK Prospective Diabetes Study Group.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.
BMJ, 317 (1998), pp. 703-713
[5.]
J.L. Clua Espuny, J. Puig Junoy, M.L. Queralt Tomás, A. Palau Galindo.
Análisis coste-efectividad de la automonitorización de la glucosa sanguínea en diabéticos tipo 2.
Gac Sanit, 14 (2000), pp. 442-448
[6.]
J.M. Pascual, C. Gonzalez, S. De Juan, C. Sánchez, B. Sánchez, M. Pérez.
Impacto económico de la diabetes mellitus en los costes de hospitalización.
Med Clin (Barc), 107 (1996), pp. 207-210
[7.]
W.M. Hart, C. Espinosa, J. Rovira.
El coste de la diabetes mellitus conocida en España.
Med Clin (Barc), 109 (1997), pp. 289-293
[8.]
B. Jönnson.
Diabetes – The cost of illness and the cost of control.
Acta Med Scand, 671 (1983), pp. 19-27
[9.]
R.M. Kaplan, W.K. Davis.
Evaluating the costs and benefits of outpatient diabetes education and nutrition counseling.
Diabetes Care, 9 (1986), pp. 81-86
[10.]
B. Leese.
Diabetes mellitus and the St Vivent Declaration. The economic implications.
Pharmaco-Economics, 7 (1995), pp. 292-307
[11.]
X. Badia, M. Roset, S. Montserrat, M. Herdman, A. Segura.
La versión española del EuroQol: descripción y sus aplicaciones. Escala Europea de Calidad.
Med Clin (Barc), 112 (1999), pp. 79
[12.]
A. Liebl, A. Neiss, A. Spannheimer, U. Reitberger, T. Wagner, A. Goërtz.
Kosten des Typ-2-Diabetes in Deutschland. Ergebnisse der CODE-2 Studie.
Dtsch Med Wschr, 126 (2001), pp. 585-589
[13.]
B. Detournay, F. Fagnani, C. Pribil, E. Eschwege.
Consommation de soins et de Biens médicaux des diabétiques de type 2 en France en 1998.
Diabetes & Metabolism (Paris), 26 (2000), pp. 225-231
[14.]
B. Costa, A. Estopa, J. Borras, A. Sabate.
Diabetes y farmacoeconomía. Eficiencia de los métodos inyectables de insulina disponibles en España.
Aten Primaria, 16 (1995), pp. 391-396
[15.]
B. Costa, J.F. Monclus, M. Huguet.
Consumo de medicamentos en la diabetes mellitus 2. Utilización y pérdida de insulina: epidemiología e implicaciones socioeconómicas. Grupo de estudio de la diabetes de Tarragona.
Med Clin (Barc), 100 (1993), pp. 241-244
[16.]
B. Costa, M. Huguet.
Consumo de medicamentos en diabetes mellitus (IV). Utilización de material reactivo y sistemas de control de la glucosa en sangre desde el punto de vista de la atención primaria. Grupo de estudio de la diabetes en Tarragona.
Med Clin (Barc), 102 (1994), pp. 321-324
[17.]
J.L. Clua Espuny, J. Puig Junoy, E. Ciurana Roca, G. García Bernal, J.F. Monclus Benet, A. González Henares, et al.
Automonitorización de la glucosa en sangre: evaluación de su prescripción y resultados en diabetes tipo 2. Grupo de investigación en atención primaria de Tortosa.
Aten Primaria, 24 (1999), pp. 316-325
[18.]
American Diabetes Association.
Economic consequences of diabetes mellitus in the US in 1997.
Diabetes Care, 21 (1998), pp. 296-309
[19.]
K. Gerard, C. Donaldson, A.K. Maynard.
The cost of diabetes.
Diabetic Med, 6 (1989), pp. 164-170
[20.]
A. Gray, M. Raikou, A. McGuire, P. Fenn, R. Stevens, C. Cull, et al.
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41).
BMJ, 320 (2000), pp. 1373-1378
[21.]
F. Henriksson, C.D. Agardh, C. Berne, J. Bolinder, F. Lönnqvist, P. Stenström, et al.
Direct medical costs for patients with type 2 diabetes in Sweden.
J Intern Med, 248 (2000), pp. 387-396
[22.]
C. Lucioni, S. Mazzi, G. Serra.
Costi e profili di trattamento farmacologico nei pazienti con diabete di tipo 2: i risultati dello studio CODE-2.
Pharmacoeconomics-Italian Research Articles, 3 (2001), pp. 1-14
[23.]
UK Prospective Diabetes Study Group.
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes (UKPDS 40).
BMJ, 317 (1998), pp. 720-726
[24.]
J.A. O'Brien, I. Caro, D. Getsios, J.J. Caro.
Diabetes in Canada: direct medical costs of major macrovascular complications.
Value in Health, 4 (2001), pp. 258-265
[25.]
D. Klonoff, D. Schwartz.
An economic analysis of interventions for Diabetes.
Diabetes Care, 23 (2000), pp. 390-404
[26.]
The Diabetes Control and Complications Trial Research Group (DCCT).
Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial.
JAMA, 276 (1996), pp. 1409-1415
[27.]
R.C. Eastman, J.C. Javitt, W.H. Herman, E.J. Dasbach, C. Copley-Merriman, W. Maier, et al.
Model of complications of NIDDM II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.
Diabetes Care, 20 (1997), pp. 685-686
[28.]
M. Roset, X. Badia, A. Benavides, M. Herdman.
The validity of the EQ-5D in children with asthma. 16th Plenary Meeting of the EuroQol Group.
Sitges, Spain, (1999, noviembre), pp. 6-9
[29.]
Badia X, Roset M, López-David C, Herdman M. Is the EQ-5D useful in estimating use of health resources in a cohort of HIV patients? 17th Plenary Meeting of the EuroQol Group.
[30.]
Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Medical Decision Making
Copyright © 2002. Sociedad Española de Salud Pública y Administración Sanitaria
Descargar PDF
Idiomas
Gaceta Sanitaria
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?